23.01.2019 23:26:59
|
Vertex Pharmaceuticals Fires COO Ian Smith
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) Wednesday said it has fired Chief Operating Officer and interim Chief Financial Officer Ian Smith due to personal behavior that violated the company's code.
Smith's termination is the result of personal behavior that violated Vertex's Code of Conduct and values and is unrelated to the Company's financial and business performance, the company said in a statement.
The company and the Board made this determination following a prompt and comprehensive investigation conducted with the assistance of independent external counsel, WilmerHale.
Paul Silva, Senior Vice President and the Company's Corporate Controller and Chief Accounting Officer since 2008, has been appointed interim CFO, effective immediately, while the Company conducts a formal search to identify a permanent CFO.
"At Vertex, we are deeply committed to our culture of diversity, inclusion and respect, and we insist that all of our employees, regardless of their seniority, live our values and adhere to our Code of Conduct," said Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex. "This decision was not related to any conduct concerning the company's operations or finances."
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vertex Pharmaceuticals Inc.mehr Nachrichten
04.02.25 |
NASDAQ Composite Index-Papier Vertex Pharmaceuticals-Aktie: So viel Gewinn hätte eine Vertex Pharmaceuticals-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
03.02.25 |
Anleger in New York halten sich zurück: NASDAQ Composite zeigt sich zum Handelsstart schwächer (finanzen.at) | |
31.01.25 |
NASDAQ-Handel NASDAQ 100 liegt zum Ende des Freitagshandels im Minus (finanzen.at) | |
31.01.25 |
Schwacher Handel in New York: NASDAQ Composite schließt in der Verlustzone (finanzen.at) | |
31.01.25 |
Börse New York in Rot: S&P 500 notiert letztendlich im Minus (finanzen.at) | |
31.01.25 |
Pluszeichen in New York: NASDAQ Composite-Börsianer greifen am Freitagnachmittag zu (finanzen.at) | |
31.01.25 |
Börse New York in Grün: S&P 500 verbucht am Freitagnachmittag Gewinne (finanzen.at) | |
31.01.25 |
Pluszeichen in New York: Pluszeichen im NASDAQ 100 (finanzen.at) |
Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen
Aktien in diesem Artikel
Vertex Pharmaceuticals Inc. | 468,90 | 1,44% |